PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP), A NEW VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-LIKE PEPTIDE IN THE RESPIRATORY-TRACT

被引:118
|
作者
UDDMAN, R
LUTS, A
ARIMURA, A
SUNDLER, F
机构
[1] UNIV LUND, DEPT MED CELL RES, S-22362 LUND, SWEDEN
[2] TULANE UNIV, SCH MED, HERBERT CTR, US JAPAN BIOMED RES LABS, NEW ORLEANS, LA 70112 USA
关键词
PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP); VASOACTIVE INTESTINAL PEPTIDE (VIP); IMMUNOCYTOCHEMISTRY; RESPIRATORY TRACT; AUTONOMIC INNERVATION; MAMMALS;
D O I
10.1007/BF00318155
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pituitary adenylate cyclase-activating peptide (PACAP) is a vasoactive intestinal peptide (VIP)-like peptide recently isolated from ovine hypothalami. Nerve fibers displaying PACAP immunoreactivity were found in the respiratory tract of rats, guinea pigs, ferrets, pigs, sheep and squirrel monkeys. A moderate supply of PACAP-immunoreactive fibers was seen in the nasal mucosa of guinea pigs. Few to moderate numbers of PACAP-containing fibers occurred in the tracheo-bronchial wall of rats, guinea pigs, ferrets, pigs, sheep and squirrel monkeys. The fibers were distributed beneath the epithelium, around blood vessels and seromucous glands, and among bundles of smooth muscle. In the lungs, the immunoreactive fibers were observed close to small bronchioli. A few PACAP-immunoreactive nerve cell bodies were seen in the sphenopalatine and otic ganglia of guinea pigs. Simultaneous double immunostaining of the respiratory tract of sheep and ferrets revealed that all PACAP-containing nerve fibers stored VIP. We suggest that neuronal PACAP may take part in the regulation of smooth muscle tone and glandular secretion.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 50 条
  • [1] PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) MIMICS THE ACTIONS OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON GASTRIC CHIEF CELLS
    RAUFMAN, JP
    SINGH, L
    CLINICAL RESEARCH, 1992, 40 (02): : A262 - A262
  • [2] VASOACTIVE-INTESTINAL-PEPTIDE, BUT NOT PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE, MODULATES THE RESPONSIVENESS OF THE GONADOTROPH TO LHRH IN MAN
    HAMMOND, PJ
    TALBOT, K
    CHAPMAN, R
    GHATEI, MA
    BLOOM, SR
    JOURNAL OF ENDOCRINOLOGY, 1993, 137 (03) : 529 - 532
  • [3] STIMULATORY ACTIONS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON PEPTIDE YY RELEASE IN THE DOG
    ZHANG, T
    MOCHIZUKI, T
    YANAIHARA, N
    GOMEZ, G
    THOMPSON, JC
    GREELEY, G
    REGULATORY PEPTIDES, 1992, 40 (02) : 286 - 286
  • [4] RECEPTORS FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE - COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS
    ARIMURA, A
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1992, 3 (08): : 288 - 294
  • [5] Central pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) decrease the baroreflex sensitivity in trout
    Lancien, Frederic
    Mimassi, Nagi
    Conlon, J. Michael
    Le Mevel, Jean-Claude
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2011, 171 (02) : 245 - 251
  • [6] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity
    Ganea, D
    Delgado, M
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (03) : 229 - 237
  • [7] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11
    Gourlet, P
    Vandermeers, A
    Robberecht, P
    DeschodtLanckman, M
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (04) : 509 - 515
  • [8] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis
    Baranowska-Bik, Agnieszka
    Kochanowski, Jan
    Uchman, Dorota
    Wolinska-Witort, Ewa
    Kalisz, Malgorzata
    Martynska, Lidia
    Baranowska, Boguslawa
    Bik, Wojciech
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 263 (1-2) : 159 - 161
  • [9] New insight in migraine pathogenesis: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
    Gazerani, Parisa
    Cairns, Brian E.
    SCANDINAVIAN JOURNAL OF PAIN, 2013, 4 (04) : 208 - 210
  • [10] VASCULAR EFFECTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE - A COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE
    ABSOOD, A
    CHEN, D
    WANG, ZY
    HAKANSON, R
    REGULATORY PEPTIDES, 1992, 40 (03) : 323 - 329